Terns Pharmaceuticals Inc
NASDAQ:TERN

Watchlist Manager
Terns Pharmaceuticals Inc Logo
Terns Pharmaceuticals Inc
NASDAQ:TERN
Watchlist
Price: 7.165 USD 12.66%
Market Cap: 608.6m USD
Have any thoughts about
Terns Pharmaceuticals Inc?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-2.3
Current
-1.5
Median
13.8
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-2.3
=
Enterprise Value
225.9m USD
/
EBITDA
-99.7m USD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-2.1
2-Years Forward
EV/EBITDA
-1.8
3-Years Forward
EV/EBITDA
-1.5

See Also

Discover More